Sökresultat - Wolf, Douglas C.

Temporal Improvement of a COVID-19-Positive Crohn's Disease Patient Treated With Bismuth Subsalicylate av Wolf, Douglas C., Wolf, Christine H., Rubin, David T.

Hämta fulltext Hämta fulltext Hämta fulltext

Predicting Outcomes and Tailoring Therapy in the Diagnosis and Treatment of IBD av Scherl, Ellen J., Seidman, Ernest G., Wolf, Douglas C.

Hämta fulltext Hämta fulltext

Community Perspectives: Combining Serology, Genetics, and Inflammation Markers for the Diagnosis of IBD and Differentiation Between CD and UC av Wolf, Douglas C., Abraham, Bincy P., Afzali, Anita, Allegretti, Paul D., Arai, Ronen

Hämta fulltext Hämta fulltext

Transcriptional Modulation of the ERK1/2 MAPK and NF-κB Pathways in Human Urothelial Cells After Trivalent Arsenical Exposure: Implications for Urinary Bladder Cancer av Bailey, Kathryn A., Wallace, Kathleen, Smeester, Lisa, Thai, Sheau-Fung, Wolf, Douglas C., Edwards, Stephen W., Fry, Rebecca C.

Hämta fulltext Hämta fulltext

Identification and Characterization of Adverse Effects in 21(st) Century Toxicology av Keller, Douglas A., Juberg, Daland R., Catlin, Natasha, Farland, William H., Hess, Frederick G., Wolf, Douglas C., Doerrer, Nancy G.

Hämta fulltext Hämta fulltext Hämta fulltext

Adherence rates and health care costs in Crohn’s disease patients receiving certolizumab pegol with and without home health nurse assistance: results from a retrospective analysis... av Wolf, Douglas C, Jaganathan, Srihari, Burudpakdee, Chakkarin, Seetasith, Arpamas, Low, Robert, Lee, Edward, Gucky, Jay, Yassine, Mohamed, Schwartz, David A

Hämta fulltext Hämta fulltext Hämta fulltext

Effects of Prenatal Exposure to a Low Dose Atrazine Metabolite Mixture on Pubertal Timing and Prostate Development of Male Long Evans Rats av Stanko, Jason P., Enoch, Rolondo R., Rayner, Jennifer L., Davis, Christine C., Wolf, Douglas C., Malarkey, David E., Fenton, Suzanne E.

Hämta fulltext Hämta fulltext Hämta fulltext

Clinical Benefit of Long-Term Adalimumab Treatment in Patients With Crohn’s Disease Following Loss of Response or Intolerance to Infliximab: 96-Week Efficacy Data From GAIN/ADHERE... av Panaccione, Remo, Sandborn, William J, D’Haens, Geert, Wolf, Douglas C, Berg, Sofie, Maa, Jen-fue, Petersson, Joel, Robinson, Anne M

Hämta fulltext Hämta fulltext Hämta fulltext

Therapeutic Drug Monitoring of Tumor Necrosis Factor Antagonists in Crohn Disease: A Theoretical Construct to Apply Pharmacokinetics and Guidelines to Clinical Practice av Vande Casteele, Niels, Feagan, Brian G, Wolf, Douglas C, Pop, Anca, Yassine, Mohamed, Horst, Sara N, Ritter, Timothy E, Sandborn, William J

Hämta fulltext Hämta fulltext Hämta fulltext

Placental Transfer of Anti-Tumor Necrosis Factor Agents in Pregnant Patients with Inflammatory Bowel Disease av Mahadevan, Uma, Wolf, Douglas C., Dubinsky, Marla, Cortot, Antoine, Lee, Scott D., Siegel, Corey A., Ullman, Thomas, Glover, Sarah, Valentine, John F., Rubin, David T., Miller, Jocelyn, Abreu, Maria T.

Hämta fulltext Hämta fulltext Hämta fulltext

A predictive data-driven framework for endocrine prioritization: a triazole fungicide case study av Paul Friedman, Katie, Papineni, Sabitha, Marty, M. Sue, Yi, Kun Don, Goetz, Amber K., Rasoulpour, Reza J., Kwiatkowski, Pat, Wolf, Douglas C., Blacker, Ann M., Peffer, Richard C.

Hämta fulltext Hämta fulltext Hämta fulltext

The codification of hazard and its impact on the hazard versus risk controversy av Doe, John E., Boobis, Alan R., Cohen, Samuel M., Dellarco, Vicki L., Fenner-Crisp, Penelope A., Moretto, Angelo, Pastoor, Timothy P., Schoeny, Rita S., Seed, Jennifer G., Wolf, Douglas C.

Hämta fulltext Hämta fulltext Hämta fulltext

A new approach to the classification of carcinogenicity av Doe, John E., Boobis, Alan R., Cohen, Samuel M., Dellarco, Vicki L., Fenner-Crisp, Penelope A., Moretto, Angelo, Pastoor, Timothy P., Schoeny, Rita S., Seed, Jennifer G., Wolf, Douglas C.

Hämta fulltext Hämta fulltext Hämta fulltext

Long-Term Efficacy and Safety of Ozanimod in Moderately to Severely Active Ulcerative Colitis: Results From the Open-Label Extension of the Randomized, Phase 2 TOUCHSTONE Study av Sandborn, William J, Feagan, Brian G, Hanauer, Stephen, Vermeire, Severine, Ghosh, Subrata, Liu, Wenzhong J, Petersen, AnnKatrin, Charles, Lorna, Huang, Vivian, Usiskin, Keith, Wolf, Douglas C, D’Haens, Geert

Hämta fulltext Hämta fulltext Hämta fulltext

Four-Year Maintenance Treatment With Adalimumab in Patients with Moderately to Severely Active Ulcerative Colitis: Data from ULTRA 1, 2, and 3 av Colombel, Jean-Frederic, Sandborn, William J, Ghosh, Subrata, Wolf, Douglas C, Panaccione, Remo, Feagan, Brian, Reinisch, Walter, Robinson, Anne M, Lazar, Andreas, Kron, Martina, Huang, Bidan, Skup, Martha, Thakkar, Roopal B

Hämta fulltext Hämta fulltext Hämta fulltext

Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis av Feagan, Brian G, Schreiber, Stefan, Wolf, Douglas C, Axler, Jeffrey L, Kaviya, Arpeat, James, Alexandra, Curtis, Rebecca I, Geransar, Parnia, Stallmach, Andreas, Ehehalt, Robert, Bokemeyer, Bernd, Khalid, Javaria Mona, O’Byrne, Sharon

Hämta fulltext Hämta fulltext Hämta fulltext

Mode of action and human relevance analysis for nuclear receptor-mediated liver toxicity: A case study with phenobarbital as a model constitutive androstane receptor (CAR) activato... av Elcombe, Clifford R., Peffer, Richard C., Wolf, Douglas C., Bailey, Jason, Bars, Remi, Bell, David, Cattley, Russell C., Ferguson, Stephen S., Geter, David, Goetz, Amber, Goodman, Jay I., Hester, Susan, Jacobs, Abigail, Omiecinski, Curtis J., Schoeny, Rita, Xie, Wen, Lake, Brian G.

Hämta fulltext Hämta fulltext Hämta fulltext

Finfish and aquatic invertebrate pathology resources for now and the future av Spitsbergen, Jan M., Blazer, Vicki S., Bowser, Paul R., Cheng, Keith C., Cooper, Keith R., Cooper, Timothy K., Frasca, Salvatore, Groman, David B., Harper, Claudia M., (Mac) Law, Jerry M., Marty, Gary D., Smolowitz, Roxanna M., Leger, Judy St., Wolf, Douglas C., Wolf, Jeffrey C.

Hämta fulltext Hämta fulltext Hämta fulltext

656: POST-VACCINATION SYMPTOMS AFTER A THIRD DOSE OF SARS-COV-2 MRNA VACCINATION IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE av Mujukian, Angela, Li, Dalin, Debbas, Philip, Banty, Andrea, Feldman, Edward J., Ha, Christina, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Solomon, Theodore, Syal, Gaurav, Targan, Stephan R., Vasiliauskas, Eric A., Ziring, David, Bonthala, Nirupama, Hampton, Melissa, Pozdnyakova, Valeriya, Gu, Phillip, Ebinger, Joseph, Joung, Sandy, Figueiredo, Jane C., Merchant, Akil, Merin, Noah, Reckamp, Karen L., Appel, Keren, Kumar, Rashmi, Boland, Brigid, Charabaty, Aline, Chiorean, Michael V., Cohen, Erica, Flynn, Ann D., Valentine, John F., Ehrlich, Adam C., Fudman, David, Glover, Sarah C., Horizon, Arash A., Karayev, Dmitry, Kretzmann, Benjamin, Hou, Jason K., Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, McConnell, Ryan, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Nimisha, Parekh, Raffals, Laura H., Rubin, David T., Sheibani, Sarah, Siegel, Corey A., Wolf, Douglas C., Younes, Ziad H., Cheng, Susan, Braun, Jonathan G., Mcgovern, Dermot P.B., Melmed, Gil

Hämta fulltext Hämta fulltext

653: PATIENTS WITH INFLAMMATORY BOWEL DISEASE HAVE IMPAIRED HUMORAL BUT PRESERVED CELLULAR RESPONSES TO SARS-COV-2 MRNA VACCINATION av Li, Dalin, Xu, Alexander, Ebinger, Joseph, Debbas, Philip, Banty, Andrea, Feldman, Edward J., Ha, Christina, Lee, Susie, Rabizadeh, Shervin, Stein, Theodore, Solomon, Theodore, Syal, Gaurav, Targan, Stephan R., Vasiliauskas, Eric A., Ziring, David, Bonthala, Nirupama, Hampton, Melissa, Mujukian, Angela, Pozdnyakova, Valeriya, Gu, Phillip, Joung, Sandy, Appel, Keren, Kumar, Rashmi, Boland, Brigid S., Charabaty, Aline, Chiorean, Michael V., Cohen, Erica, Damas, Oriana M., Flynn, Ann D., Valentine, John F., Ehrlich, Adam C., Fudman, David, Glover, Sarah C., Horizon, Arash A., Karayev, Dmitry, Kretzmann, Benjamin, Hou, Jason K., Hwang, Caroline, Lazarev, Mark, Lum, Donald, Fausel, Rebecca, Reddy, Swapna, McConnell, Ryan, Mattar, Mark, Metwally, Mark, Ostrov, Arthur, Parekh, Nimisha K., Raffals, Laura H., Rubin, David T., Sheibani, Sarah, Siegel, Corey A., Wolf, Douglas C., Younes, Ziad H., Kaplan, Ian M., Prostko, John, Sobhani, Kimia, Merchant, Akil, Cheng, Susan, Braun, Jonathan G., Mcgovern, Dermot P.B., Melmed, Gil

Hämta fulltext Hämta fulltext